Keywords: اصلاح شده به منظور درمان; Mild; Moderate; Asthma; Lebrikizumab; AE; adverse event; AQLQ(S); Standardised Asthma Quality of Life Questionnaire; ATA; anti-therapeutic antibodies; FeNO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1â¯s; HLGT; high level group t
مقالات ISI اصلاح شده به منظور درمان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اصلاح شده به منظور درمان; The trial was registered under NCT02433834 at; http://www.clinicaltrials.gov; Asthma; Co-suspension delivery technology; Glycopyrronium; Inhaled corticosteroid use; Metered dose inhaler; ACQ-5; Asthma Control Questionnaire-5; AE; adverse event; AUC0-3;
Keywords: اصلاح شده به منظور درمان; Allergen challenge; allergen peptides; allergy; allergic rhinoconjunctivitis; allergic rhinitis; environmental exposure unit; epitope; grass; immunotherapy; synthetic peptide immunoregulatory epitope; AE; Adverse events; AIT; Allergen immunotherapy; ARC;
Keywords: اصلاح شده به منظور درمان; Asthma; lebrikizumab; IL-13; type 2 inflammation; periostin; uncontrolled; antibody; FEV1; AE; Adverse event; Feno; Fraction of exhaled nitric oxide; HR; Hazard ratio; ICS; Inhaled corticosteroid; mITT; Modified intent-to-treat; PEF; Peak expiratory flow;
Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease
Keywords: اصلاح شده به منظور درمان; Co-suspension delivery technology; Formoterol fumarate dihydrate; Glycopyrronium; Metered dose inhaler; Spacer; Valved holding chamber; AE; adverse event; ANOVA; analysis of variance; AUC0-12; area under the curve from 0 to 12â¯h; BMI; body mass index;
Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial
Keywords: اصلاح شده به منظور درمان; ACMG; American College of Medical Genetics and Genomics; ADHD RS-IV IA; Attention Deficit Hyperactivity Disorder Rating Scale IV, inattention subscore; AE; adverse event; ANCOVA; analysis of covariance; CANTAB; Cambridge Neuropsychological Test Automated
Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month ex
Keywords: اصلاح شده به منظور درمان; Glycaemic control; Hypoglycaemia; Insulin glargine; Type 2 diabetes; AE; adverse event; ANCOVA; analysis of covariance; BL; baseline; BMI; body mass index; CI; confidence interval; FPG; fasting plasma glucose; Gla-100; glargine 100; Gla-300; glargine 300;
Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer
Keywords: اصلاح شده به منظور درمان; AJCC; American Joint Committee on Cancer; ANA; antinuclear antibody; CI; confidence intervals; EGFR; epidermal growth factor; HR; hazard ratio; ISR; injection site reactions; ITT; intent-to-treat; mITT; modified intent-to-treat; MUC1; mucin 1; NSCLC; non-
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials
Keywords: اصلاح شده به منظور درمان; AED; antiepileptic drug; ALT; alanine aminotransferase; CBZ; carbamazepine; CI; confidence interval; DRESS; drug reaction with eosinophilia and systemic symptoms; ESL; eslicarbazepine acetate; GCP; Good Clinical Practice; mITT; modified intent-to-treat; M
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease
Keywords: اصلاح شده به منظور درمان; Pathology; Healing; Inflammation; Treatment; AE; adverse events; ANCOVA; analysis of covariance; CDSD; celiac disease symptom diary; DGP; deamidated gliadin peptide; GFD; gluten-free diet; GI; gastrointestinal; ICDSQ; Impact of Celiac Disease Symptoms Que
Visual Field Change and 24-Hour IOP-Related Profile with a Contact Lens Sensor in Treated Glaucoma Patients
Keywords: اصلاح شده به منظور درمان; CLS; contact lens sensor; GAT; Goldmann applanation tonometry; IOP; intraocular pressure; MD; mean deviation; mITT; modified intent-to-treat; PLS; partial least squares;
Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis
Keywords: اصلاح شده به منظور درمان; RM-131; Phase 2 Trial; Gastrointestinal Motility; Dose Comparison; ADA; antidrug antibody; AE; adverse event; ANCOVA; analysis of covariance; DGSSD; Diabetic Gastroparesis Symptom Severity Diary; ECG; electrocardiogram; GCSI-DD; Gastroparesis Cardinal Sym
Efficacy of 2Â months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study
Keywords: اصلاح شده به منظور درمان; Allergen-specific immunotherapy; birch pollen allergy; Bet v 1; contiguous overlapping peptides; synthetic peptides; aluminum hydroxide; IgG4; IgE; desensitization; clinical trial; AE; Adverse event; AIT; Allergen-specific immunotherapy; ANCOVA; Analysis
Immunogenicity and safety of a single dose of a CRM-conjugated meningococcal ACWY vaccine in children and adolescents aged 2-18 years in Taiwan: Results of an open label study
Keywords: اصلاح شده به منظور درمان; AE; adverse event; CI; confidence interval; GMT; geometric mean titre; GMR; GMT ratio; hSBA; serum bactericidal activity assay with human complement; MITT; modified intent-to-treat; SAE; serious adverse event; Meningococcal disease; Immunogenicity; Safety
Research ArticleBoceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response
Keywords: اصلاح شده به منظور درمان; HCV; hepatitis C virus; BOC; boceprevir; PR; peginterferon with ribavirin; SVR; sustained virological response; TW; treatment week; NS3/4A; nonstructural proteins 3 and 4A; IU/ml; international units per milliliter; mITT; modified intent-to-treat; ITT; in
MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments
Keywords: اصلاح شده به منظور درمان; AE; adverse event; Cmax; maximum concentration; DHE; dihydroergotamine mesylate; FEV1; forced expiratory volume in 1 second; ICHD-II; International Classification of Headache Disorders, 2nd edition; mITT; modified intent-to-treat;
TROPICS 1: A Phase III, Randomized, Double-blind, Placebo-controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters
Keywords: اصلاح شده به منظور درمان; AE; adverse event; CI; confidence interval; CRBSI; catheter-related bloodstream infection; CVC; central venous catheter; DVT; deep vein thrombosis; ICH; intracranial hemorrhage; MITT; modified intent-to-treat; PBO-TNK-TNK; placebo, tenecteplase, and tenec